Dole Food Company, Inc. (DOLE): Monkey Business in the Banana Fields

Page 1 of 2

Dole Food Company, Inc. (NYSE:DOLE) has been producing, marketing and distributing fresh vegetables and fruits to Americans for over a century. With a core focus on bananas and pineapples, it also markets packaged fruit, salads and freshly packed vegetables. Shareholders of the company went bananas when they came to learn that its own CEO David Murdock had made an offer to purchase the entire company. A point to note is that Mr. Murdock currently owns around 39.5% of Dole, and he valued his company at approximately at $1.1 billion.

What Is He Trying to Sell to Common Stockholders?

Dole Food Company, Inc.Stock of the company was trading at $10.20 on June 10, the day the offer was made. However, market pushed the price to $12.29 the next day after Mr. Murdock made the offer to purchase the remaining 60.5% of the company at $12 per share.

In the proposal to Dole Food Company, Inc. (NYSE:DOLE)’s board of directors, the current CEO tried to provide enough numbers to support his claims that this transaction favors the common stockholders, including:

The offer embeds approximately 18% premium to shareholders considering Dole’s closing share price was $10.20 on June 10 (based on his offer of $12 per share).

This is an approximately 19% premium to shareholders based on the volume-weighted average share price for the month preceding June 10.

By considering any assumption of debt obligations, the offer provides a 10.2-fold bid based on Dole Food Company, Inc. (NYSE:DOLE)’s expected EBITDA of $150 for the entire year of 2013

Stockholders Won’t Buy it, Sued Management

However, regardless of the compelling letter and numbers, investors are worried that the CEO is utilizing his power in the company and “inside” information regarding the operations of Dole Food Company, Inc. (NYSE:DOLE)’s business in an attempt to buy out the company “on the cheap.” Bloomberg reported that the skeptical shareholders have already sued the directors of Dole in Delaware Chancery Court with allegations that if the offer is accepted, it will not maximize shareholder value.

It is a reasonable expectation that if the CEO himself is willing to purchase shares at $12, he must know how to increase the value further. Hence, Dole Food Company, Inc. (NYSE:DOLE)’s stock has been slowly climbing beyond the offer price and is currently trading at $12.86 as of June 18. If we look closely, the proposal issues prerogatives that at $12, the bid will be paying 10.2x EBITDA to common stockholders. However, if we include non-core assets to the equation, at 10.2x EBITDA the bid should have been at $16.4 per share – higher than Dole’s 52-week high of $15.19.

How Other Monkeys Are Handling Their Bananas?

One of the major revenue streams of Dole is marketing products based on bananas. Two of Dole’s top competitors are Chiquita Brands International, Inc. (NYSE:CQB) and Fresh Del Monte Produce Inc (NYSE:FDP). As a high volume and low cost producer and with 64% revenue coming from bananas, Chiquita Brands International, Inc. (NYSE:CQB) is North America’s top banana producer. It went through some major internal restructuring in recent years and currently the company has an EPS of negative -$8.46. However, with a 52-week stock price range of $4.62 – $11.23 the company has increased its market capitalization by 143.07% in the last 12 months. Fresh Del Monte Produce Inc (NYSE:FDP), under the DEL MONTE brand, has a global operation of producing fruits and vegetables, including bananas, similar to Dole. Although it currently boasts a positive EPS of $2.10, over the last 12 months the company’s stock price moved somewhat chaotically with a positive trend. Its stock price has a 52-week range of $22.27 – $27.97, which constitutes a mere 25.6% gain. Comparing these two major competitor’s stock gains to Dole reveals that as a whole the banana industry has been doing well despite low demand and the falling price of bananas.

Page 1 of 2

Biotech Insider Alert - $6 Stock To Hit $40

$200 Million Dollar Healthcare Hedge Fund's #1 Best Idea Right Now

The best healthcare hedge fund out there right now is one of the largest shareholders in this biotech stock. The fund returned more than 20% in each of the last 2 years with a virtually fully hedged portfolio, and it's sending out a BUY signal on this biotech stock. Get your FREE REPORT today (retail value of $300)

This is a FREE report from Insider Monkey. Credit Card is NOT required.
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The Best Romance Movies of all Time

The Most Wanted Drug Lords

The Oldest Money Managers

The Greatest Directors in the World

Largest Animals in the World

World’s Most Expensive Desserts

Best Selling Comic Books of All Time

A-list Actors who Sabotaged Their Career

Rappers With a College Degree

The Best Jazz Albums of all Time

The Most Influential Jazz Musicians

The World’s Most Famous Photographers

The Best Oscar-Winning Songs

Most Influential Choreographers Ever

Most Expensive Department Stores in the World

The Most Expensive Stolen Paintings in the World

The World’s Most Expensive Teas

Top Oscar Record Holders

The Most Expensive Flowers in the World

Countries With a Booming Film Industry

Most Expensive Cupcakes in the World

Uncommon European Escapes

The Most Stolen Artists in History

Best Travel Destinations in Australia

World’s Most Expensive Musical Instruments

World’s Most Famous Animals

Most Expensive Cakes in the World

Most Expensive Kosher Champagne in the World

Most Expensive Kosher Wine in the World

The Most Surprisingly Dark Fairy Tales

Most Popular Travel Destinations in Asia

The 10 Most Expensive Dresses Ever Worn to the Oscars

World’s Most Visited Art Museums

Best Countries for Photographers to Work in

Best Paid Jobs in the Film Industry

The Most Renowned Recovered Paintings Ever

Child Stars That Turned out Just Fine

Books That Were Banned in the Past Century

World’s Richest Dancers

Best Remedies against Bad Breath

Foods That Improve Your Skin Texture

Best-Selling Children’s Books of all Time

Foods That Boost Your Libido

Best-Selling Books of all Time

The Most Expensive Academy Awards Jewelry in History

Most Expensive Japanese Restaurant In New York City

The Best B-Boy Movies

Most Awesome Hip Hop Documentaries

Foods That Stain Your Teeth

Richest Doctors in the World

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 129% in 2.5 years!! Wondering How?

Download a complete edition of our newsletter for free!